TXMD · Categories · Form 4
TXMD - SEC Form 4 insider transactions
TherapeuticsMD Inc. (TXMD) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for TXMD
- SEC Form 4 filed by Director Thompson Tommy G4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Director Naughton Gail K4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Director Collins Cooper C.4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Walker Marlan D4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- Director Collins Cooper C. converted options into 8,500 shares, increasing direct ownership by 16% to 60,516 units (SEC Form 4)4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- Director Naughton Gail K converted options into 8,500 shares (SEC Form 4)4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- Director Thompson Tommy G converted options into 8,500 shares, increasing direct ownership by 143% to 14,454 units (SEC Form 4)4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- Chief Executive Officer Walker Marlan D converted options into 8,281 shares, increasing direct ownership by 13% to 70,846 units (SEC Form 4)4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- Walker Marlan D converted options into 70,000 shares and sold $43,684 worth of shares (19,050 units at $2.29), increasing direct ownership by 439% to 62,565 units (SEC Form 4)4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- Rubric Capital Management Lp was granted 877,192 shares (SEC Form 4)4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Ziegler Joseph was granted 7,500 shares4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Thompson Tommy G4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Naughton Gail K4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Collins Cooper C.4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Rubric Capital Management Lp4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Walker Marlan D (Amendment)4/A - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Walker Marlan D4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Donegan Michael C4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Walker Marlan D4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Donegan Michael C4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Rubric Capital Management Lp returned $38,657,000 worth of Series A Preferred Stock to the company (29,000 units at $1,333.00) (Amendment)4/A - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Donegan Michael C converted options into 5,940 shares and sold $8,621 worth of shares (1,697 units at $5.08), increasing direct ownership by 56% to 11,853 units to cover taxes4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Donegan Michael C converted options into 4,365 shares and sold $6,988 worth of shares (1,309 units at $5.34), increasing direct ownership by 67% to 7,610 units (for tax liability)4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Rubric Capital Management Lp sold $38,657,000 worth of Series A Preferred Stock (29,000 units at $1,333.00)4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Rubric Capital Management Lp bought $90,284 worth of shares (14,825 units at $6.09)4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Bernick Brian converted options into 3,167 shares and sold $6,621 worth of shares (1,255 units at $5.28), increasing direct ownership by 98% to 3,872 units to satisfy withholding tax4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Walker Marlan D converted options into 2,554 shares and sold $5,185 worth of shares (1,048 units at $4.95), increasing direct ownership by 29% to 6,685 units to satisfy withholding tax4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Glickman Mark A sold $2,165 worth of shares (440 units at $4.92) and converted options into 1,734 shares to cover withholding tax4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Donegan Michael C converted options into 3,476 shares and sold $4,345 worth of shares (910 units at $4.78), increasing direct ownership by 129% to 4,554 units to satisfy withholding obligation4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Rubric Capital Management Lp bought $115,639 worth of shares (20,413 units at $5.66)4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Naughton Gail K sold $20,635 worth of shares (3,922 units at $5.26), closing all direct ownership in the company4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Rubric Capital Management Lp bought $7,000,000 worth of Series A Preferred Stock (7,000 units at $1,000.00)4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Russell Angus C.4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Bisaro Paul4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Collins Cooper C.4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Thompson Tommy G4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Musing Jules A.4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Naughton Gail K4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Ling Karen4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Rubric Capital Management Lp bought $7,000,000 worth of Series A Preferred Stock (7,000 units at $1,000.00)4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Ling Karen converted options into 1,984 shares, increasing direct ownership by 76% to 4,591 units4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Naughton Gail K converted options into 1,984 shares, increasing direct ownership by 102% to 3,922 units4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Russell Angus C. converted options into 1,984 shares, increasing direct ownership by 52% to 5,792 units4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Thompson Tommy G converted options into 2,976 shares, increasing direct ownership by 100% to 5,954 units4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Bisaro Paul converted options into 1,984 shares, increasing direct ownership by 50% to 5,922 units4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Musing Jules A. converted options into 1,984 shares, increasing direct ownership by 97% to 4,022 units4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Collins Cooper C. converted options into 1,984 shares, increasing direct ownership by 4% to 46,722 units4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Rubric Capital Management Lp bought $2,666,800 worth of shares (565,000 units at $4.72) and bought $12,333,150 worth of Series A Preferred Stock (15,000 units at $822.21)4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Rubric Capital Management Lp bought $467,458 worth of shares (82,580 units at $5.66)4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Glickman Mark A4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Donegan Michael C4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Walker Marlan D4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by O'Dowd Hugh4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Glickman Mark A4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Donegan Michael C4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Walker Marlan D4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by O'Dowd Hugh4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4 filed by Walker Marlan D4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Walker Marlan D converted options into 230,000 shares, increasing direct ownership by 796% to 258,908 units4 - TherapeuticsMD, Inc. (0000025743) (Issuer)
- SEC Form 4: Donegan Michael C converted options into 115,000 shares and sold $15,947 worth of shares (29,790 units at $0.54), increasing direct ownership by 602% to 99,368 units (for tax liability)4 - TherapeuticsMD, Inc. (0000025743) (Issuer)